Nurix Therapeutics, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 23 →InsidersNo open-market buys. 3 insiders sold $2.4M, 13 of 25 sales on a 10b5-1 plan.→HoldersBlackRock 8.5%Vestal Point Capital 7.8%Deep Track Capital 7.5%→PeersClosest companies: CCCC, IMRX, LONA→
From the filings
Figures
- Revenue
- $36.8Mlast 12 months
- Net income
- −$341.4Mlast 12 months
- Operating cash flow
- −$260.3Mlast 12 months
- Cash and equivalents
- $67.7Mat the last balance sheet
- Shares outstanding
- 103.7M shareson issue